Progesterone, Micronized
Brand names: Crinone, Progesterone, Prometrium
At a glance
- Medicare prescriptions, 2024
- 453,549
- Medicare drug cost
- $17.7M
- Average cost per prescription
- $39.06
- Clinicians who prescribed it
- 14,497
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.
From the FDA-approved prescribing information (label dated May 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- OB-GYN (Obstetrics & Gynecology) 39.0%
- Nurse Practitioners 25.1%
- Family Medicine 14.1%
- Internal Medicine 6.2%
- Physician Assistants 5.4%
- Naturopaths 1.9%
- Endocrinology & Diabetes 1.1%
- General Practice 1.0%
- Certified Nurse-Midwives 1.0%
- Emergency Medicine 0.6%
- Urogynecology 0.6%
- Urology 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 106% from 2019 to 2024.
Biggest change by state since 2019
- Oklahoma +172%
- Louisiana +166%
- Utah +165%
- Missouri +150%
- Washington +149%
- New York (smallest change) +55%
- California (smallest change) +57%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 5 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Bionpharma Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 100 mg | yellow oval capsule, 13 mm | P 3 |
| 200 mg | white oval capsule, 15 mm | P 4 |
Ingenus Pharmaceuticals, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 100 mg | white oval insert | G1 |
Nucare Pharmaceuticals,inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 200 mg | white oval capsule, 15 mm | P2 |
Redpharm Drug
| Strength | Looks like | Imprint |
|---|---|---|
| 100 mg | white round capsule, 8 mm | P1 |
Remedyrepack Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 100 mg | yellow oval capsule, 13 mm | P 3 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
Drug makers reported $1,591 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Ferring Pharmaceuticals Inc. $1,591
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Feb 2021 · Dr. Reddy's Laboratories, Inc. · Class II
Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.